Cargando…
Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up
Several adjunct therapies to the gold standard anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections have been discussed for the treatment of neovascular age-related macular degeneration (nAMD). Low-dose stereotactic radiotherapy (SRT) showed the potential to lower the treatmen...
Autores principales: | Steinemann, Alexandra, Hoffmann, Laura, Hatz, Katja B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138223/ https://www.ncbi.nlm.nih.gov/pubmed/34054474 http://dx.doi.org/10.1159/000514241 |
Ejemplares similares
-
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response
por: Hatz, Katja, et al.
Publicado: (2014) -
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Kondo, Naoshi, et al.
Publicado: (2009) -
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019) -
Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Liu, Ke, et al.
Publicado: (2019) -
Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Jin, Ki Won, et al.
Publicado: (2021)